Session Details

[D2-A3]Issues and Solutions for Data Integrity in GLP: Exploring Best Practices through Discussions with PMDA, JSQA, and Bioanalysis Facilities

Thu. Mar 5, 2026 2:45 PM - 4:10 PM JST
Thu. Mar 5, 2026 5:45 AM - 7:10 AM UTC
Medium Hall(2nd Floor)
Chairman:Nozomu Koseki(Sunplanet Co.,Ltd.), Takeshi Okuzono(Sekisui Medical Co., Ltd.)

[D2-A3-01]The points which PMDA expects to the test facility

*Kenji Nakano1 (1. Pharmaceuticals and Medical Devices Agency)
Comment()

[D2-A3-02]Addressing OECD GLP Data Integrity Guidance
- Case Studies Using DI Risk Management -

*Tomoharu Shimokawa1,2 (1. Japan Society of Quality Assurance GLP Division, 2. Toray Research Center, Inc.)
Comment()

[D2-A3-03]Issues and Solutions for Data Integrity in GLP: Exploring Best Practices through Discussions with PMDA, JSQA, and Bioanalysis Facilities

*Nozomu Koseki1, *Takeshi Okuzono2 (1. Sunplanet Co., Ltd., 2. Sekisui Medical Co., Ltd.)
Comment()